Annual Accounts Payable
$143.57 M
-$22.41 M-13.50%
31 December 2023
Summary:
Amneal Pharmaceuticals annual accounts payable is currently $143.57 million, with the most recent change of -$22.41 million (-13.50%) on 31 December 2023. During the last 3 years, it has fallen by -$9.57 million (-6.25%). AMRX annual accounts payable is now -13.50% below its all-time high of $165.98 million, reached on 31 December 2022.AMRX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$235.00 M
+$35.42 M+17.75%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly accounts payable is currently $235.00 million, with the most recent change of +$35.42 million (+17.75%) on 30 September 2024. Over the past year, it has increased by +$57.60 million (+32.47%). AMRX quarterly accounts payable is now -61.70% below its all-time high of $613.62 million, reached on 30 September 2020.AMRX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.5% | +32.5% |
| 3 y3 years | -6.3% | -60.1% |
| 5 y5 years | +25.0% | -52.6% |
AMRX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -13.5% | +9.5% | -60.1% | +79.3% |
| 5 y | 5 years | -13.5% | +39.4% | -61.7% | +128.1% |
| alltime | all time | -13.5% | +105.1% | -61.7% | +235.7% |
Amneal Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $235.00 M(+17.7%) |
| June 2024 | - | $199.58 M(+13.8%) |
| Mar 2024 | - | $175.32 M(+22.1%) |
| Dec 2023 | $143.57 M(-13.5%) | $143.57 M(-19.1%) |
| Sept 2023 | - | $177.40 M(+27.1%) |
| June 2023 | - | $139.53 M(-70.1%) |
| Mar 2023 | - | $467.42 M(+181.6%) |
| Dec 2022 | $165.98 M(+26.6%) | $165.98 M(-68.8%) |
| Sept 2022 | - | $531.46 M(-5.4%) |
| June 2022 | - | $561.69 M(+4.1%) |
| Mar 2022 | - | $539.73 M(+311.7%) |
| Dec 2021 | $131.08 M | $131.08 M(-77.8%) |
| Sept 2021 | - | $589.41 M(-1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $596.23 M(+3.8%) |
| Mar 2021 | - | $574.32 M(+275.0%) |
| Dec 2020 | $153.14 M(+48.6%) | $153.14 M(-75.0%) |
| Sept 2020 | - | $613.62 M(+2.4%) |
| June 2020 | - | $599.49 M(-1.2%) |
| Mar 2020 | - | $606.92 M(+489.1%) |
| Dec 2019 | $103.02 M(-10.3%) | $103.02 M(-79.2%) |
| Sept 2019 | - | $495.86 M(-1.8%) |
| June 2019 | - | $505.14 M(-9.6%) |
| Mar 2019 | - | $558.75 M(+386.5%) |
| Dec 2018 | $114.85 M(+64.0%) | $114.85 M(-7.8%) |
| Sept 2018 | - | $124.54 M(-26.3%) |
| June 2018 | - | $169.05 M(+141.4%) |
| Dec 2017 | $70.01 M | $70.01 M |
FAQ
- What is Amneal Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual accounts payable year-on-year change?
- What is Amneal Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly accounts payable year-on-year change?
What is Amneal Pharmaceuticals annual accounts payable?
The current annual accounts payable of AMRX is $143.57 M
What is the all time high annual accounts payable for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual accounts payable is $165.98 M
What is Amneal Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, AMRX annual accounts payable has changed by -$22.41 M (-13.50%)
What is Amneal Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of AMRX is $235.00 M
What is the all time high quarterly accounts payable for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly accounts payable is $613.62 M
What is Amneal Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, AMRX quarterly accounts payable has changed by +$57.60 M (+32.47%)